Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort studyShow others and affiliations
2017 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 7, no 9, article id e015723Article in journal (Refereed) Published
Abstract [en]
OBJECTIVES: The aim of this study was to explore whether recording in primary care of a previously recorded hospital diagnosis was associated with increased patient utilisation of recommended medications.
DESIGN: Registry-based prospective cohort study.
SETTING AND PARTICIPANTS: 19 072 patients with a hospital discharge diagnosis of transient ischaemic attack (TIA), stroke or acute coronary syndrome from hospitals in Stockholm County 2010-2013 were included in the study.
MAIN OUTCOME MEASURE: The outcome of the study was medication dispensation as a marker of adherence to recommended medications. Adherence was defined as having had at least two filled prescriptions in the third year following hospital discharge.
RESULTS: Recording a diagnosis was associated with higher utilisation of all recommended medications with the exception of antihypertensives in patients with TIA. The differences between the groups with and without a recorded diagnosis remained after adjusting for age, sex, index year and visits to private practitioners. Dispensation of antithrombotics was high overall, 80%-90% in patients without a recorded diagnosis and 90%-94% for those with a diagnosis. Women with recorded ischaemic stroke/TIA/acute coronary syndrome were dispensed more statins (56%-71%) than those with no recorded diagnosis (46%-59%). Similarly, 68%-83% of men with a recorded diagnosis were dispensed statins (57%-77% in men with no recorded diagnosis). The rate of diagnosis recording spanned from 15% to 47% and was especially low in TIA (men 15%, women 16%).
CONCLUSION: Recording a diagnosis of TIA/stroke or acute coronary syndrome in primary care was found to be associated with higher dispensation of recommended secondary preventive medications. Further study is necessary in order to determine the mechanisms underlying our results and to establish the utility of our findings.
Place, publisher, year, edition, pages
London, UK: BMJ Publishing Group Ltd, 2017. Vol. 7, no 9, article id e015723
Keywords [en]
clinical pharmacology, myocardial infarction, preventive medicine, primary care, quality in health care, stroke
National Category
Medical and Health Sciences General Practice
Identifiers
URN: urn:nbn:se:oru:diva-80698DOI: 10.1136/bmjopen-2016-015723ISI: 000412650700067PubMedID: 28939569Scopus ID: 2-s2.0-85029836855OAI: oai:DiVA.org:oru-80698DiVA, id: diva2:1414915
2020-03-162020-03-162024-01-02Bibliographically approved